LETI Pharma, the Experimental Laboratory for Immunogenic Therapeutics, is an independent, family-owned, biopharmaceutical company. Since its creation, in 1919, LETI Pharma has been working in immunotherapy based on the use of allergens, applying principals of personalized medicine, and a patient approach keeping with the “One Health” philosophy. LETIPharma integrates two lines of business, and several areas of work: HUMAN HEALTH - Immunology and Allergy, centered on the production of allergen extracts for allergy diagnosis and treatment. - Dermatology and skin care, which centers its activity on the development of dermo-pharmaceutical products as well as other special products designed for personal care and treatment of skin abnormalities. ANIMAL HEALTH A line specialized in producing solutions for Veterinary Immunology and Dermatology for the prevention, diagnosis and treatment of the major immune-mediated diseases found in pets, like allergy and leishmaniasis. LETI Pharma is a Spanish multinational with solid international presence.
| Website | https://www.leti.com |
| Revenue | $9.1 million |
| Employees | 627 (0 on RocketReach) |
| Founded | 1919 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharma, Immunotherapy, Family Owned, Allergens, Independent, Therapeutics, Experimental Therapeutics, Drug Development, Pharmaceutical Research, Biotechnology, Clinical Trials, Vaccine Development, Innovative Medicines, Precision Medicine, New Drugs, Treatment, Health, Medicine |
| Competitors | Galderma, Emergent BioSolutions, Revance, Actavis plc (now Allergan), AVITA Medical, Sientra, Inc., Medytox, MediWound Ltd., Hugel Inc. +23 more (view full list) |
Looking for a particular LETI Pharma employee's phone or email?
The LETI Pharma annual revenue was $9.1 million in 2026.